Brigham's Gawande picked as CEO of Amazon-Berkshire Hathaway-JPMorgan healthcare initiative

Amazon, Berkshire Hathaway and JPMorgan Chase announced Atul Gawande, MD, MPH, as the new CEO for its partnership on U.S. employee healthcare. A surgeon at Brigham and Women’s Hospital in Boston and professor at Harvard Medical School, he will begin his new role July 9.

“I’m thrilled to be named CEO of this healthcare initiative,” said Atul, “I have devoted my public health career to building scalable solutions for better healthcare delivery that are saving lives, reducing suffering, and eliminating wasteful spending both in the U.S. and across the world. Now I have the backing of these remarkable organizations to pursue this mission with even greater impact for more than a million people, and in doing so incubate better models of care for all. This work will take time but must be done. The system is broken, and better is possible.”

The 52-year-old founded Ariadne Labs, an innovation lab focused on public health. He is also a staff writer for The New Yorker and has written four best-selling books.

“Talent and dedication were manifest among the many professionals we interviewed,” said Warren Buffett, Berkshire Hathaway chairman and CEO. “All felt that better care can be delivered and that rising costs can be checked. Jamie, Jeff and I are confident that we have found in Atul the leader who will get this important job done.”

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Trimed Popup
Trimed Popup